Skip to main content
. 2020 Nov;8(21):1402. doi: 10.21037/atm-20-2420

Figure 3.

Figure 3

The OS rates of HBV-related HCC patients using PSM comparative analyses of ALPPS with TACE. There was no statistical difference in OS rates of HBV-related HCC patients between ALPPS and TACE (P=0.178). OS, overall survival; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; PSM, propensity score matching; ALPPS, associating liver partition and portal vein ligation for staged hepatectomy; TACE, transarterial chemoembolization.